Correction to: Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials

Affiliations

• ¹ Clinical Pharmacology and Pharmacometrics, Biogen, 225 Binney Street, Cambridge, MA, USA. bharathkumar.kandadimuralidharan@biogen.com.
• ² Kowalski PMetrics Consulting, LLC, 44569 Larchwood Drive, Northville, MI, USA.
• ³ Clinical Pharmacology and Pharmacometrics, Biogen, 225 Binney Street, Cambridge, MA, USA.
• ⁴ Clinical Development, Biogen, 225 Binney Street, Cambridge, MA, USA.
• ⁵ Development Imaging, Biogen, 225 Binney Street, Cambridge, MA, USA.